Marijuana Business News

Synonyms: 
stocks
business
Mon
11
Mar

The top cannabis stocks with explosive European exposure

The press has spent a considerable amount of time, focused on cannabis developments in the U.S. and in Canada. 

Canada, for example, just legalized cannabis throughout the country.  Corporate America is quickly waking up to the opportunity, transforming multi-billion-dollar industries.  U.S. states are approving the use of cannabis for recreational or medicinal use.  

However, at the same time, the cannabis story is proving to be just as exciting in Europe.

According to Canaccord Genuity as noted by The Boston Globe, “CBD, has become a ‘trending ingredient’ in a range of consumer goods and is now highly visible in pharmacies and health stores. It estimates the CBD product market in Europe was worth 750 million euros ($857 million) to 1 billion euros in 2018…”

Mon
11
Mar

Here's what to do if marijuana stocks crash

Billions of dollars are shifting from the black market to legal marijuana marketplaces and that's sent marijuana stocks soaring to new highs. However, there's increasing concern the economy will weaken because of interest rate increases and trade wars, and if so, pot stocks could tumble. If there's a widespread sell-off in marijuana stocks, here's what you should do.

Don't let fear determine your next move

We're hardwired to avoid danger and it doesn't matter if that danger presents itself in the form of a falling account balance or a raging rhinoceros. However, panicking isn't a recipe for successfully navigating the stock market.

Mon
11
Mar

Better marijuana stock: Aurora Cannabis vs. Green Thumb Industries

Aurora Cannabis (NYSE:ACB) is off to a fantastic start in 2019. Its share price is up more than 55%. But there's a marijuana stock with a market cap less than one-third of Aurora's that is enjoying an even better start to the year. That stock is Green Thumb Industries (NASDAQOTH:GTBIF), which is up close to 70% year to date.

Which of these two marijuana stocks is the better pick for investors now? Here's how Aurora Cannabis and Green Thumb Industries stack up against each other.

Mon
11
Mar

Marijuana stocks are up 50% in 2019, time to sell?

Volatility is the name of the game when it comes to investing in the cannabis sector.

The sector is prone to large price swings and have been a trader’s dream. Year to date, the Global Cannabis Stock Index is up almost 50% in less than three months.

Is it time to lock-in your profits? Let’s take a look.

Mon
11
Mar

Martha Stewart switches cherry pie for pot as she enters the booming cannabis business

She is 77 years old and best known for dispensing advice on such vital matters as how to tidy up a linen closet or make the perfect cheesy vegetable frittata.

Now Martha Stewart is branching out into the marijuana business, as America's most celebrated domestic goddess teams up with a Canadian cannabis business, Canopy Growth Corporation.

Mon
11
Mar

Amazon may sell marijuana sooner than expected

The marijuana industry is evolving at a rapid pace. Back in 1995, a mere 25% of all respondents in Gallup's annual survey were in favor of legalizing marijuana, and not a single U.S. state or country around the world had given the green light to cannabis.

Today, two-thirds of all respondents in Gallup's annual survey now favor the legalization of pot in the U.S., with 33 U.S. states having legalized the drug for medical purposes, and 10 allowing adult consumption. There are also two countries (Canada and Uruguay) worldwide to OK recreational weed, with more than two dozen medically legal countries.

Mon
11
Mar

Investing in CBD stocks offers opportunity but risks

Cannabidiol (CBD) has taken off lately, and the recent passage of the Farm Act in December has accelerated interest in the cannabinoid found in cannabis plants that was also the active ingredient in the first FDA approved drug derived from botanical cannabis, GW Pharmaceuticals's Epidiolex, which is indicated for the treatment of seizures in treatment-resistant forms of two types of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Products containing CBD are becoming increasingly available in a variety of formats and through an increasing number of venues, with consumers able to access products derived from industrial hemp through mail order, convenience stores, health food stores, some restaurants and coffee shops and now even malls.

Fri
08
Mar

4 Canadian cannabis stocks under pressure in 2019

Most cannabis stocks have railed since the beginning of the year, with the average year-to-date return of our sample of 157 cannabis stocks coming in at 32.6%. However, not all stocks have been big winners. Today we have identified four Canadian cannabis stocks experiencing sharp declines year to date, which could represent an oversold opportunity.

Fri
08
Mar

Buds & Duds: MYM Nutraceuticals stock on the rise after 120-acre hemp partnership

Cannabis stocks faced a difficult outlook Thursday, mirroring US markets as a whole.

The Marijuana Index, which tracks the cannabis sector in the US and Canada, was down 2.5% to 277.4.

Buds

MYM Nutraceuticals Inc (OTCMKTS:MYMMF) (CSE:MYM) stock is doing well Thursday thanks to a new partnership with Elite Ventures Group LLC on 120 acres of CBD-rich hemp in Nevada. Based on Elite’s prior cultivation success in similar circumstances, the parcel represents potential revenue of more than $26 million, of which MYM is entitled to 50%, less sales and processing fees. Investors liked what they heard, sending the share price up nearly 10% to $0.43 on the OTC Markets and more than 7% to $0.57 on the CSE.

Fri
08
Mar

How startup nation could make medical marijuana 'The next Coca Cola'

Last month, on the day the cabinet approved the exporting of medicinal cannabis, attorney Yair Geva got the green light for signing a deal with a foreign company, about to be listed on NASDAQ, which intends to invest in an Israeli company, the valuation of which instantly spiked.

Pages

Subscribe to RSS - Marijuana Business News